Studymoderate evidence
A unified framework for systematic curation and evaluation of aging biomarkers.
Nature aging·November 1, 2025·PMID 41188602
Why it mattersAging biomarkers are increasingly used in clinical and research settings, but their validation has been inconsistent. This paper provides a standardized evaluation framework and clarifies that different biomarkers are optimal for different outcomes, helping specialists select appropriate tools for risk stratification or healthspan assessment.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled